19.85USD+5.70%Mkt Cap: 1.54B $P/E: —1d ago
Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operate…
Industry Peers
Medical DevicesIndicators:|
Key Statistics
Company
Market Cap1.54B $
Enterprise Value3.24B $
Revenue (TTM)1.64B $
Gross Profit831.62M $
Net Income (TTM)-516.47M $
Revenue/Share21.41 USD
Last Price19.85 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees4.4K
CountryUS
SectorHealthcare
IndustryMedical Devices
ISINUS4579852082
Valuation
P/E (Trailing)—
P/E (Forward)7.58
PEG0.67
EV/EBITDA10.50
EV/Revenue1.97
P/S0.94
P/B1.48
EPS (TTM)-6.47
EPS (Forward)2.62
52W Range
8.70096% of range20.26
52W High20.26 USD
52W Low8.700 USD
Profitability
Gross Margin50.86%
Oper. Margin10.41%
EBITDA Margin18.75%
Profit Margin-31.58%
ROE-49.50%
ROA-14.34%
Growth
Revenue Growth2.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF50.38M $
CapEx (TTM)95.64M $
FCF Margin4.21%
FCF Yield4.49%
Net Debt1.78B $
Net Debt/EBITDA5.76
Balance Sheet
Debt/Equity1.95
Current Ratio3.38
Quick Ratio1.53
Book Value/Sh13.39 USD
Cash/Share3.413 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split2:1
Split DateJan 4, 2017
Analyst Consensus
Rating2.7 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)18.00 USD
Upside (mean)-9.3%
Target Range11.00 USD – 27.00 USD
$11.00-9.3% to mean$27.00
# Analysts8
Ownership
Shares Out.77.80M
Float58.70M
Insiders14.29%
Institutions100.18%
Short Interest
Short Ratio6.5d
Short % Float11.33%
Short % Out.8.22%
Shares Short6.39M
Short (prev mo.)7.99M
Technical
SMA 5016.42 (+20.9%)
SMA 20013.05 (+52.1%)
Beta1.22
S&P 52W Chg20.25%
Avg Vol (30d)880.33K
Avg Vol (10d)871.52K
Technical Indicators
RSI (14)68.9
MACD0.7264
MACD Signal0.7300
MACD Hist.-0.0036
BB Upper19.42 USD
BB Middle18.17 USD
BB Lower16.93 USD
BB Width13.71%
ATR (14)0.8649 USD
Vol Ratio (20d)1.37x